Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMLODIPINE vs AMLODIPINE\HYDROCHLOROTHIAZIDE\OLMESARTAN MEDOXOMIL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AMLODIPINE vs AMLODIPINE\HYDROCHLOROTHIAZIDE\OLMESARTAN MEDOXOMIL: Safety Overview

Metric AMLODIPINE AMLODIPINE\HYDROCHLOROTHIAZIDE\OLMESARTAN MEDOXOMIL
Total FAERS Reports 64,924 793
Deaths Reported 10,161 23
Death Rate 15.7% 2.9%
Hospitalizations 26,787 434
Average Patient Age 62.8 yrs 67.3 yrs
% Female Patients 57.0% 58.4%
FDA Approval Date Apr 12, 2011 N/A
Manufacturer Teva Pharmaceuticals USA, Inc. N/A
Route ORAL N/A
Marketing Status Prescription N/A